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Impact of Cyclin-Dependent

Introduction
The cyclin-dependent kinase 4 (CDK4) participates in the regulation of cell cycle progression and transcription [1] . Increased activity of cyclin-dependent kinases including CDK4 is observed in cancer and CDK inhibition has been shown to induce G1 arrest and apoptosis [2] [3] [4] [5] [6] [7] [8] . The efficacy of CDK inhibitors is primarily attributed to altered transcription of antiapoptosis family members, cell cycle regulators, as well as p53 and NF-κB-responsive gene targets [1, 9] . On the other hand, CDK4 has been implicated in the regulation of neuronal cell death [10] . Activation of CDK4 leads to hyper-phosphorylation of the pRb family member p130 with subsequent p130 dissociation from the transcription factor E2F4 and expression of E2F binding genes including the transcription factors B-and C-Myb, which in turn stimulate the expression of the pro-apoptotic BH3-only protein Bim [10] . Furthermore, CDK4 is a powerful modulator of mitochondrial functions via phosphorylation of mitochondrial targets [11] .
Similar to the apoptosis of nucleated cells, erythrocytes are able to undergo suicidal death called eryptosis [12, 13] . Triggers of eryptosis include activation of Ca
2+
-permeable cation channels with Ca 2+ entry, activation of Ca
-sensitive K + channels, exit of KCl with osmotically obliged water and, thus, cell shrinkage. Cytosolic Ca 2+ further elicits scrambling of the erythrocyte membrane resulting in phosphatidylserine (PS) externalization [13] . Extracellular Cl --sensitive osmotic shrinkage opens eryptosis-triggering non-selective cation channels in the erythrocyte cell membrane which are also activated by oxidative stress [12] . As erythrocytes are devoid of nuclei, any stimulators or inhibitors of eryptosis must be effective without influencing gene expression [13] .
The present study explored whether CDK4 protein is present in erythrocytes and if so, whether it influences eryptosis.
Materials and Methods
Erythrocytes, incubations and solutions
Leukocyte-depleted erythrocytes from concentrates were provided by the blood bank of the University of Tübingen. The volunteers providing erythrocytes gave informed consent. The study has been approved by the Ethical commission of the University of Tübingen. The erythrocytes were incubated at 37°C in Ringer solution containing (in mM): 125 NaCl, 5 KCl, 1 MgSO 4 , and 32 HEPES/NaOH (pH 7.4), 5 glucose, and 1 CaCl 2 at a hematocrit of 0.4% in a total volume of 1 ml. Where indicated, chloride was replaced by gluconate or 0.3 mM tert-butyl hydroperoxide [tBOOH] added to the Ringer solution. The CDK4 inhibitors II (1, 4-Dimethoxyacridine-9(10H)-thione, NSC 625987) and III (5-(N-(4-Methylphenyl)amino)-2-methyl-4,7-dioxobenzothiazole, ryuvidine), purchased from Calbiochem (Cat #: 219477 and 219478, Bad Soden, Germany), were dissolved in DMSO and added to the respective solutions, at concentrations as indicated. Solvent (0.1%) did not influence annexin V binding (data not shown).
Western blotting
To examine the presence of CDK4 protein in human erythrocytes, 150 µl erythrocyte pellet was lysed in 50 ml of 20 mM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)/NaOH (pH 7.4). Ghost membranes were pelleted (15,000 g for 20 min at 4°C) and lysed in 200 µl lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 0.5% SDS, 1mM NaF, 1mM Na 3 VO 4 , 0.4% ß-mercaptoethanol) containing protease inhibitor cocktail (Sigma, Taufkirchen, Germany). For whole erythrocyte lysates, 4 µl of erythrocytes were lysed in 200 µl lysis buffer. In all cases, 80 µg of protein were solubilized in Laemmli sample buffer at 95°C for 5 min and resolved by 10% SDS-PAGE. For immunoblotting, proteins were electrotransferred onto a PVDF membrane and blocked with 5% nonfat milk in TBS-0.10% Tween 20 (TBST) at room temperature for 1 h. Then, the membrane was incubated with monoclonal mouse anti-CDK4 antibody (1:2000; 30 kDa, Cell Signaling, Freiburg, Germany) at 4°C overnight. After washing 3 times with TBST (10 min each), the blots were incubated with horseradish peroxidase conjugated secondary anti-rabbit antibody (1:2000; Cell Signaling) for 1 h at room temperature. After washing, antibody binding was detected with the 
Determination of phosphatidylserine exposure and forward scatter
For FACS analysis erythrocytes were washed after incubation once in Ringer solution containing 5 mM CaCl 2 . The cells were then stained with Annexin V-Fluos (Roche, Mannheim, Germany) at a 1:500 dilution. After 15 min, samples were measured by flow cytometric analysis (FACS-Calibur from Becton Dickinson; Heidelberg, Germany). Cells were analysed by forward scatter, and annexin V-fluorescence intensity was measured in fluorescence channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. 
Measurement of intracellular Ca
Statistics
Data are expressed as arithmetic mean ± SEM, and statistical analysis was made by paired ANOVA with Tukey's test as post-test. Values of p<0.05 were considered statistically significant. n denotes the number of different erythrocyte specimens studied.
Results
According to Western blotting, human erythrocytes express the protein kinase CDK4. As shown in Fig. 1 , the respective bands show the presence of CDK4 protein in membrane lysates from isolated human erythrocytes as well as from whole blood. Bands in K562 cell lysates were slightly higher presumably due to differential posttranslational modification of CDK4 in K562 cells as compared to erythrocytes. Whole cell lysates from isolated human erythrocytes further showed CDK4 expression. Further experiments were performed to elucidate, whether CDK4 is involved in the regulation of suicidal erythrocyte death or eryptosis.
In a first series of experiments, eryptosis was stimulated by replacement of Cl -with gluconate, which leads to profound isosmotic cell shrinkage due to exit of Cl -paralleled by K + exit. According to forward scatter, which reflects alterations of cell volume, Cl -removal was followed by a sharp, significant decrease of cell volume ( Fig. 2A and 2B ). As shown in Fig. 2A and 2B, addition of CDK4 inhibitor II and III did not significantly modify erythrocyte forward scatter in the presence of Cl -ions. However, cell shrinkage following Cl -removal was significantly abated by treatment with CDK4 inhibitor III but not by CDK4 inhibitor II ( Fig. 2A and 2B ). Cl -removal is a powerful inducer of PS-externalization on the erythrocyte membrane. PS-exposing erythrocytes were identified in FACS analysis utilizing annexin-V-binding. To this end, Cl -removal was followed by the expected significant increase in annexin-V-binding ( Fig. 2C and 2D) 
in the absence of Cl -ions, an effect reaching statistical significance at a concentration of 5 µM (Fig. 2C) . Similarly, the CDK4 inhibitor III did not significantly modify PS-exposure in the presence of extracellular Cl -ions but significantly attenuated PS-exposure in the absence of Cl -ions, an effect reaching statistical significance at a concentration of 0.2 µM (Fig. 2C) . Enhanced PS-exposure following Cl -removal is known to be stimulated by nonselective cation channels which elicit increased cytosolic Ca 2+ activity in erythrocytes. Thus, Fluo3 fluorescence was employed to determine erythrocyte Ca
2+
. As shown in Fig. 3A and 3B, Cl -removal significantly increased Fluo3 fluorescence. Treatment with CDK4 inhibitors II and III did not significantly modify Fluo 3 fluorescence in the presence of extracellular Cl -ions but markedly blunted the increase of Fluo3 fluorescence following Cl -removal, an effect reaching statistical significance at 5 µM and 0.2 µM concentration respectively for inhibitors II and III (Fig. 3A and 3B) .
Additional series of experiments explored the effect of pharmacological inhibition of CDK4 on eryptosis triggered by oxidative stress, which was accomplished by exposure of erythrocytes for 30 minutes to 0.3 mM of the oxidant tert-butyl-hydroperoxide (tBOOH). As illustrated in Fig. 4 , exposure to tBOOH (0.3 mM) was followed by a sharp, significant increase in erythrocyte PS-exposure. The addition of CDK4 inhibitors II and III again did not significantly modify PS-exposure in the absence of tBOOH, but significantly curtailed PS-exposure in the presence of tBOOH indicating the efficacy of CDK4 inhibitors II and III in curtailing eryptosis triggered by oxidative stress (Fig. 4) . 
Discussion
The present observations reveal that the protein kinase CDK4 protein is present in human erythrocytes and that the CDK4 inhibitors II and III significantly interfere with the stimulation of eryptosis following Cl-depletion and oxidative stress.
Both oxidative stress and removal of extracellular Cl -ions are known to foster increase in cytosolic Ca 2+ activity [12, 13] . Herein, we observed that both CDK4 inhibitors II and III thwart eryptosis by mitigating the increase of cytosolic Ca 2+ activity following removal of extracellular Cl -ions. Beyond the activation of scramblase and Ca
2+
-sensitive K + channels [12] , enhanced cytosolic Ca 2+ activity participates in the modification of the cytoskeleton and in the activation of a wide variety of Ca
-sensitive enzymes such as transglutaminase [14] , phospholipases [15] , calpain [14] , protein kinases and phosphatases [16, 17] . Calpain activation is responsible for the membrane blebbing during suicidal erythrocyte death [12] .
Recently, hematopoiesis was shown to be affected in mice with a combined deficiency of CDK2 and CDK4 [18] . Interestingly, the combined deficiency of these cyclin-dependent kinases resulted in increased erythrocyte cell volume [18] . The CDK4 inhibitors used in this study are chemically unrelated compounds which have previously been shown to potently inhibit CDK4 kinase activity. CDK4 inhibitor II (NSC 625987) is an ATP-competitive thioacridone compound and has been shown to possess a greater selectivity for CDK4 over other cyclin-dependent kinases including CDK1 and CDK2 [19] . On the other hand, the dioxobenzothiazole compound CDK4 inhibitor III (ryuvidine) was reported to suppress CDK4 activity by a higher magnitude as compared to CDK2 kinase [20] . In the present study, we have shown that CDK4 protein is present in human erythrocytes and pharmacological inhibition of CDK4 modulates eryptosis. The broad spectrum of kinase inhibition elicited by these inhibitors and off-target effects, nevertheless, warrants further investigation to clarify the putative role of CDK4 kinase in erythrocyte survival. A wide variety of erythrocyteexpressed kinases further participate in the eryptosis machinery such as AMPK [21] , CK1α [22] , Janus kinase 3 [23] , p38 MAPK [24] and PAK2 [25] . Whether these kinases influence CDK4 activity during eryptosis remains to be shown. Oxidative stress is a pathophysiologically relevant trigger of suicidal erythrocyte death in vivo as many clinical conditions with enhanced eryptosis are also associated with redox imbalance [26, 27] . Animal experiments have confirmed that erythrocytes subjected to oxidative stress have reduced lifespan in vivo and are rapidly cleared from the circulation [28] . Interestingly, cellular redox balance is decisive in the regulation of cyclin-dependent kinase-sensitive cell cycle [29] which fosters the convergence of different cell cycle signaling pathways on regulators of cyclin-dependent kinase activity such as p16, p27, and cyclin D1 [30, 31] . Due to the absence of key organelles, nucleus and mitochondria, it is not known whether these mechanisms could similarly be operative in erythrocytes.
Noticeably, we observed that the CDK4 inhibitors attenuated oxidant-induced eryptosis with different efficacies in contrast to the inhibition of eryptosis following removal of extracellular Cl -ions. According to our data, CDK4 inhibitor III showed a more robust amelioration of cytosolic Ca 2+ activity as compared to inhibitor II following removal of extracellular Cl -ions. Removal of Cl -ions triggers PGE 2 release which, in turn is associated with activation of non-selective cation channels and subsequent upregulation of cytosolic Ca 2+ activity [32] . On the other hand, oxidative stress, in addition to enhanced cytosolic Ca 2+ activity, is also associated with activation of caspases [27] and [33] . It is, therefore, possible that the CDK4 inhibitors II and III differentially target these mechanisms, independently of CDK4 kinase inhibition, in mitigating eryptosis due to oxidative stress or removal of extracellular Cl -ions. Eryptosis is enhanced by erythrocyte age [34] , and is triggered by a wide variety of anemia-causing xenobiotics and endogeneous substances [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] . Furthermore, eryptosis participates in the pathophysiology of several clinical disorders such as iron deficiency, hepatic failure, chronic kidney disease, sepsis, malignancy, Wilson's disease and presumably metabolic syndrome [12, 13, [49] [50] [51] . Eryptosis may further influence erythrocytes stored for transfusion [52] . Eryptotic erythrocytes are rapidly phagocytosed and cleared from circulating blood, thus enhancing the risk of anemia [12] . Eryptosis further stimulates blood clotting [53] and may compromise microcirculation by increased adhesion of eryptotic erythrocytes to the vascular wall [54] .
In conclusion, the present observations demonstrate that erythrocytes express CDK4 and provide evidence that pharmacological CDK4 inhibition interferes with suicidal erythrocyte death.
